Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Validation of Shortness of Breath Questionnaire in COPD
NCT00411372Phase 3Withdrawn
- Sponsor
- GSK
- Start
- Nov 2006
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of salmeterol + fluticasone in chronic obstructive pulmonary disease (COPD), sponsored by GSK. Planned start Nov 2006; status: withdrawn.
02
Drugs
salmeterol + fluticasone
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00411372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411372.